We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Kilroy Realty
KRC
$4.06B
| $44M | 0.11% |
1,463,823
+264,222
| +22% | +$7.7M |
|
227
Intuitive Surgical
ISRG
$134B
| $44M | 0.11% |
128,593
+3,008
| +2% | +$910K |
|
|
ANSS
228
DELISTED
Ansys
ANSS
| $43.8M | 0.11% |
132,744
-22,209
| -14% | -$7.04M |
|
229
Wells Fargo
WFC
$273B
| $43.4M | 0.11% |
1,016,353
-28,329
| -3% | -$1.14M |
|
230
Vail Resorts
MTN
$4.99B
| $43.2M | 0.11% |
171,696
-15,000
| -8% | -$3.66M |
|
231
Progressive
PGR
$126B
| $43.2M | 0.11% |
326,130
-10,247
| -3% | -$1.37M |
|
|
LTHM
232
DELISTED
Livent Corporation
LTHM
| $42.8M | 0.11% |
1,560,000
-70,000
| -4% | -$1.68M |
|
233
CenterPoint Energy
CNP
$25.8B
| $42.7M | 0.11% |
1,463,216
-10,554
| -0.7% | -$312K |
|
234
Bright Horizons
BFAM
$3.17B
| $42.6M | 0.11% |
460,531
-275,961
| -37% | -$23.3M |
|
235
Entegris
ENTG
$19.6B
| $42.6M | 0.11% |
384,068
-61,437
| -14% | -$5.6M |
|
236
Pultegroup
PHM
$22.5B
| $42.5M | 0.11% |
547,475
-17,467
| -3% | -$1.18M |
|
237
Public Storage
PSA
$55.4B
| $42.5M | 0.11% |
145,510
+104,579
| +256% | +$30.5M |
|
238
Structure Therapeutics
GPCR
$2.76B
| $42.2M | 0.1% |
1,014,700
-38,102
| -4% | -$1.07M |
|
239
Robert Half
RHI
$3.86B
| $41.8M | 0.1% |
555,928
-91,919
| -14% | -$6.56M |
|
240
PayPal
PYPL
$46.2B
| $41.6M | 0.1% |
622,825
-245,401
| -28% | -$16.7M |
|
241
Centene
CNC
$34.3B
| $40.8M | 0.1% |
605,127
+372,177
| +160% | +$24.8M |
|
|
ETNB
242
DELISTED
89bio
ETNB
| $40.4M | 0.1% |
2,133,905
-219,210
| -9% | -$3.85M |
|
243
Tractor Supply
TSCO
$17.2B
| $40.4M | 0.1% |
913,885
+522,940
| +134% | +$24M |
|
244
Trex
TREX
$4.45B
| $40.3M | 0.1% |
614,172
-302,279
| -33% | -$16.9M |
|
245
Constellation Brands
STZ
$20.9B
| $40.1M | 0.1% |
162,743
+50,484
| +45% | +$11.8M |
|
246
Weatherford International
WFRD
$6.35B
| $39.8M | 0.1% |
599,083
-13,275
| -2% | -$817K |
|
247
Aecom
ACM
$8.18B
| $39.6M | 0.1% |
467,615
-86,900
| -16% | -$7.13M |
|
248
T-Mobile US
TMUS
$196B
| $39.6M | 0.1% |
285,077
-236,370
| -45% | -$33.2M |
|
249
Paychex
PAYX
$41.2B
| $39.5M | 0.1% |
353,267
+2,082
| +0.6% | +$228K |
|
250
Tetra Tech
TTEK
$9.34B
| $39.5M | 0.1% |
1,205,390
+214,435
| +22% | +$6.31M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.